Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
Publication
, Journal Article
Sanli, Y; Zukotynski, K; Mittra, E; Chen, DL; Nadel, H; Niederkohr, RD; Subramaniam, RM
Published in: Clin Nucl Med
December 2018
There are recent advances, namely, a standardized method for reporting therapy response (Hopkins criteria), a multicenter prospective cohort study with excellent negative predictive value of F-FDG PET/CT for N0 clinical neck, a phase III multicenter randomized controlled study establishing the value of a negative posttherapy F-FDG PET/CT for patient management, a phase II randomized controlled study demonstrating radiation dose reduction strategies for human papilloma virus-related disease, and Food and Drug Administration approval of nivolumab for treatment of recurrent head and neck squamous cell carcinoma.
Duke Scholars
Published In
Clin Nucl Med
DOI
EISSN
1536-0229
Publication Date
December 2018
Volume
43
Issue
12
Start / End Page
e439 / e452
Location
United States
Related Subject Headings
- Squamous Cell Carcinoma of Head and Neck
- Randomized Controlled Trials as Topic
- Radiopharmaceuticals
- Positron Emission Tomography Computed Tomography
- Nuclear Medicine & Medical Imaging
- Multimodal Imaging
- Magnetic Resonance Imaging
- Humans
- Head and Neck Neoplasms
- Fluorodeoxyglucose F18
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanli, Y., Zukotynski, K., Mittra, E., Chen, D. L., Nadel, H., Niederkohr, R. D., & Subramaniam, R. M. (2018). Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer. Clin Nucl Med, 43(12), e439–e452. https://doi.org/10.1097/RLU.0000000000002247
Sanli, Yasemin, Katherine Zukotynski, Erik Mittra, Delphine L. Chen, Helen Nadel, Ryan D. Niederkohr, and Rathan M. Subramaniam. “Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.” Clin Nucl Med 43, no. 12 (December 2018): e439–52. https://doi.org/10.1097/RLU.0000000000002247.
Sanli Y, Zukotynski K, Mittra E, Chen DL, Nadel H, Niederkohr RD, et al. Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer. Clin Nucl Med. 2018 Dec;43(12):e439–52.
Sanli, Yasemin, et al. “Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.” Clin Nucl Med, vol. 43, no. 12, Dec. 2018, pp. e439–52. Pubmed, doi:10.1097/RLU.0000000000002247.
Sanli Y, Zukotynski K, Mittra E, Chen DL, Nadel H, Niederkohr RD, Subramaniam RM. Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer. Clin Nucl Med. 2018 Dec;43(12):e439–e452.
Published In
Clin Nucl Med
DOI
EISSN
1536-0229
Publication Date
December 2018
Volume
43
Issue
12
Start / End Page
e439 / e452
Location
United States
Related Subject Headings
- Squamous Cell Carcinoma of Head and Neck
- Randomized Controlled Trials as Topic
- Radiopharmaceuticals
- Positron Emission Tomography Computed Tomography
- Nuclear Medicine & Medical Imaging
- Multimodal Imaging
- Magnetic Resonance Imaging
- Humans
- Head and Neck Neoplasms
- Fluorodeoxyglucose F18